Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Alcon Research

Overview

An unmasked trial after bilateral implantation of AcrySof® ReSTOR®, SA60D3 IOL . Enrolled are at least 30 patients or as much as possible from the doctor's clinical practice perspective. 6 months follow-up after IOL implant in the 2nd eye

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Visual Outcomes

Interventions

Acrysof ReSTOR multifocal IOLDEVICE

Implanted into the study eye following cataract extraction surgery

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Able to complete all required postoperative visits; Planned cataract removal by phaco; 21 years of age or older, either gender or any race; potential postoperative visual acuity of 20/20; astigmatism ≦1.0D measured by keratometry in study eye(s);clear int Exclusion Criteria: * Signs of capsular tear, significant anterior chamber hyphema;zonular rupture; corneal pathology and refractive surgery;hypercritical patient; patients with unrealistic expectations in post-op VA; happy to wear glasses;occupational night drivers

Locations (1)

Alcon Call Center

Fort Worth, Texas, United States

Outcomes

Primary Outcomes

Near,intermediate,distance visual acuity

Time frame: pre-op;1 week after 1st eye surgery,1month and 6 month after 2nd eye surgery

Secondary Outcomes

contrast sensitivity

Time frame: 6 month after 2nd eye surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.